Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation

Jae Hoon Shim, Won-Min Jo, Won Jae Chung, Jae Ho Chung

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The progress in anti-platelet therapy and percutaneous coronary intervention led to reconfigure indications of hybrid re-vascularisation. However, there are still some controversies over indication, timing and patient management during the procedure. The case discussed here is a patient who was diagnosed with myocardial infarction and treated with hybrid re-vascularisation. The patient underwent stent insertion followed by bypass surgery. After the hybrid procedure, the patient was stable but eventually died on the 12th day after the surgery owing to unexpected stent thrombosis. We discuss the current controversy over hybrid re-vascularisation, variables that can affect the outcome and the requirement for establishing accurate logistics based on our case.

Original languageEnglish
Pages (from-to)419-421
Number of pages3
JournalEuropean Journal of Cardio-thoracic Surgery
Volume36
Issue number2
DOIs
Publication statusPublished - 2009 Aug 1

Fingerprint

Coronary Artery Bypass
Stents
Thrombosis
Percutaneous Coronary Intervention
Ambulatory Surgical Procedures
Blood Platelets
Myocardial Infarction
Therapeutics

Keywords

  • Anti-platelet therapy
  • Hybrid re-vascularisation
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation. / Shim, Jae Hoon; Jo, Won-Min; Chung, Won Jae; Chung, Jae Ho.

In: European Journal of Cardio-thoracic Surgery, Vol. 36, No. 2, 01.08.2009, p. 419-421.

Research output: Contribution to journalArticle

@article{49fe8a73c2e14cd6a0767fa7dc39c893,
title = "Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation",
abstract = "The progress in anti-platelet therapy and percutaneous coronary intervention led to reconfigure indications of hybrid re-vascularisation. However, there are still some controversies over indication, timing and patient management during the procedure. The case discussed here is a patient who was diagnosed with myocardial infarction and treated with hybrid re-vascularisation. The patient underwent stent insertion followed by bypass surgery. After the hybrid procedure, the patient was stable but eventually died on the 12th day after the surgery owing to unexpected stent thrombosis. We discuss the current controversy over hybrid re-vascularisation, variables that can affect the outcome and the requirement for establishing accurate logistics based on our case.",
keywords = "Anti-platelet therapy, Hybrid re-vascularisation, Percutaneous coronary intervention",
author = "Shim, {Jae Hoon} and Won-Min Jo and Chung, {Won Jae} and Chung, {Jae Ho}",
year = "2009",
month = "8",
day = "1",
doi = "10.1016/j.ejcts.2009.04.006",
language = "English",
volume = "36",
pages = "419--421",
journal = "European Journal of Cardio-thoracic Surgery",
issn = "1010-7940",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation

AU - Shim, Jae Hoon

AU - Jo, Won-Min

AU - Chung, Won Jae

AU - Chung, Jae Ho

PY - 2009/8/1

Y1 - 2009/8/1

N2 - The progress in anti-platelet therapy and percutaneous coronary intervention led to reconfigure indications of hybrid re-vascularisation. However, there are still some controversies over indication, timing and patient management during the procedure. The case discussed here is a patient who was diagnosed with myocardial infarction and treated with hybrid re-vascularisation. The patient underwent stent insertion followed by bypass surgery. After the hybrid procedure, the patient was stable but eventually died on the 12th day after the surgery owing to unexpected stent thrombosis. We discuss the current controversy over hybrid re-vascularisation, variables that can affect the outcome and the requirement for establishing accurate logistics based on our case.

AB - The progress in anti-platelet therapy and percutaneous coronary intervention led to reconfigure indications of hybrid re-vascularisation. However, there are still some controversies over indication, timing and patient management during the procedure. The case discussed here is a patient who was diagnosed with myocardial infarction and treated with hybrid re-vascularisation. The patient underwent stent insertion followed by bypass surgery. After the hybrid procedure, the patient was stable but eventually died on the 12th day after the surgery owing to unexpected stent thrombosis. We discuss the current controversy over hybrid re-vascularisation, variables that can affect the outcome and the requirement for establishing accurate logistics based on our case.

KW - Anti-platelet therapy

KW - Hybrid re-vascularisation

KW - Percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=67650072492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650072492&partnerID=8YFLogxK

U2 - 10.1016/j.ejcts.2009.04.006

DO - 10.1016/j.ejcts.2009.04.006

M3 - Article

C2 - 19560933

AN - SCOPUS:67650072492

VL - 36

SP - 419

EP - 421

JO - European Journal of Cardio-thoracic Surgery

JF - European Journal of Cardio-thoracic Surgery

SN - 1010-7940

IS - 2

ER -